[EN] COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION<br/>[FR] COMPOSÉS DESTINÉS À RÉDUIRE LA PRODUCTION DE BÊTA-AMYLOÏDE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2012009309A1
公开(公告)日:2012-01-19
Compounds of the formula (I) are provided, including pharmaceutically acceptable salts thereof: which modulate β-amyloid peptide (β-AP) production, and are useful in the treatment of Alzheimer's Disease and other conditions affected by -amyloid peptide (β-AP) production.
COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION
申请人:Boy Kenneth M.
公开号:US20120028994A1
公开(公告)日:2012-02-02
The present disclosure provides a series of compounds of the formula (I)
which modulate β-amyloid peptide (β-AP) production and are useful in the treatment of Alzheimer's Disease and other conditions affected by β-amyloid peptide (β-AP) production.
Compounds for the reduction of β-amyloid production
申请人:Boy Kenneth M.
公开号:US08486952B2
公开(公告)日:2013-07-16
The present disclosure provides a series of compounds of the formula (I)
which modulate β-amyloid peptide (β-AP) production and are useful in the treatment of Alzheimer's Disease and other conditions affected by β-amyloid peptide (β-AP) production.
Compounds for the reduction of beta-amyloid production
申请人:Boy Kenneth M.
公开号:US08637523B2
公开(公告)日:2014-01-28
Compounds of the formula (I) are provided, including pharmaceutically acceptable salts thereof:
which modulate β-amyloid peptide (β-AP) production, and are useful in the treatment of Alzheimer's Disease and other conditions affected by β-amyloid peptide (β-AP) production.